Liminatus Share Price

Liminatus Share Price

NASDAQ: LIMNW | Micro Cap | Healthcare
$0.04
+$0.04 (--%) Last updated on 21 Nov, 2026 | 02:25 IST
  • Performance
  • Chart
  • Fundamentals
  • About
  • Price history
  • FAQs

Liminatus Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$0.06 - $0.15
Volume
N/A
Average Traded
N/A

Liminatus Share Price Chart

Line chart of the Liminatus price trend over the selected period. The price rose overall, ranging from 0.04 to 0.04, ending at 0.04.
$0.00$0.00
L
Show Current Price
H

Liminatus Stock Fundamentals & Key Indicators

Market Cap
$888383.18
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Liminatus

Liminatus Pharma Inc is a clinical-stage biopharmaceutical company engaged in developing cancer therapies and treatments. The company is developing a next generation CD47 immune checkpoint inhibitor that enables cancer cells to evade detection by the immune system. Anti-CD47 monoclonal antibodies generally induce anemia and thrombocytopenia due to their binding to red blood cells and platelets. The Liminatus CD47 mAb has shown to preferentially bind to immune cells, but not to red blood cells and platelets and does not induce hemolysis. The clinical candidate is currently in the late preclinical stage.

Liminatus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.04
$0.04
-33.93%
Feb 2026
$0.13
$0.06
-60.00%
Sep 2025
$0.14
$0.14
-33.33%
Aug 2025
$0.21
$0.21
+16.02%
Jul 2025
$0.24
$0.18
-24.27%
Jun 2025
$0.09
$0.24
+165.56%
May 2025
$0.18
$0.09
N/A

Liminatus Share Price FAQs